close
MENU
Investment
3 mins to read

AFT’s Maxigesic IV to be made and sold in China

Listed pharma company signed exclusive licensing deal for intravenous form of its pain relief medicine in world’s second-largest pharma market.

Maxigesic IV will now be sold in nine of the 10 largest pharma markets in the world.

Dual-listed AFT Pharmaceuticals has signed a deal to make and sell the intravenous form of its proprietary pain relief medicine, Maxigesic IV, in China, the largest pharma market in Asia and second-largest in the world.

The deal, the ninth for Maxigesic IV out of the top 10 pharma markets worldwide,

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Fiona Rotherham Tue, 01 Oct 2024
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Company profile
Powered by:
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Company profile
Powered by:
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
AFT’s Maxigesic IV to be made and sold in China
Investment,
106076
true